These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L. Cancer Res; 2009 Jul 15; 69(14):5761-7. PubMed ID: 19584283 [Abstract] [Full Text] [Related]
3. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma. Diao S, Zhang JF, Wang H, He ML, Lin MC, Chen Y, Kung HF. Proteomics; 2010 Oct 15; 10(20):3723-31. PubMed ID: 20859956 [Abstract] [Full Text] [Related]
4. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N. Gastroenterology; 2008 Jul 15; 135(1):257-69. PubMed ID: 18555017 [Abstract] [Full Text] [Related]
5. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M. J Pathol; 2008 Dec 15; 216(4):418-27. PubMed ID: 18925646 [Abstract] [Full Text] [Related]
7. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Liu X, Wang T, Wakita T, Yang W. Virology; 2010 Mar 01; 398(1):57-67. PubMed ID: 20006370 [Abstract] [Full Text] [Related]
8. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S. Genes Chromosomes Cancer; 2009 Jul 01; 48(7):615-23. PubMed ID: 19396864 [Abstract] [Full Text] [Related]
9. MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers. Wang X, Lam EK, Zhang J, Jin H, Sung JJ. Biochem Biophys Res Commun; 2009 Sep 18; 387(2):376-80. PubMed ID: 19607815 [Abstract] [Full Text] [Related]
10. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S. FEBS J; 2009 Jun 18; 276(11):2966-82. PubMed ID: 19490101 [Abstract] [Full Text] [Related]
11. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M. Oncogene; 2008 Sep 25; 27(43):5651-61. PubMed ID: 18521080 [Abstract] [Full Text] [Related]
12. High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. Chung GE, Yoon JH, Myung SJ, Lee JH, Lee SH, Lee SM, Kim SJ, Hwang SY, Lee HS, Kim CY. Oncol Rep; 2010 Jan 25; 23(1):113-9. PubMed ID: 19956871 [Abstract] [Full Text] [Related]
13. [Detection of miR-122a and miR-224 expression in hepatocellular carcinoma by real-time fluorescence quantitative RT-PCR]. Liu ZR, Chen XW, Qiao XH, Wang R, Xiang Z. Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr 25; 29(4):751-3. PubMed ID: 19403413 [Abstract] [Full Text] [Related]
14. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. Carcinogenesis; 2010 May 25; 31(5):766-76. PubMed ID: 19843643 [Abstract] [Full Text] [Related]
15. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. Fan CG, Wang CM, Tian C, Wang Y, Li L, Sun WS, Li RF, Liu YG. Oncol Rep; 2011 Nov 25; 26(5):1281-6. PubMed ID: 21725618 [Abstract] [Full Text] [Related]
17. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Guo L, Liu Y, Bai Y, Sun Y, Xiao F, Guo Y. Eur J Cancer; 2010 Jun 25; 46(9):1692-702. PubMed ID: 20371173 [Abstract] [Full Text] [Related]
18. [Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR]. Zhao Y, Jia HL, Zhou HJ, Dong QZ, Fu LY, Yan ZW, Sun J, Ren N, Ye QH, Qin LX. Zhonghua Gan Zang Bing Za Zhi; 2009 Jul 25; 17(7):526-30. PubMed ID: 19912688 [Abstract] [Full Text] [Related]
19. Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Yu J, Wang F, Yang GH, Wang FL, Ma YN, Du ZW, Zhang JW. Biochem Biophys Res Commun; 2006 Oct 13; 349(1):59-68. PubMed ID: 16934749 [Abstract] [Full Text] [Related]
20. Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. Haller F, von Heydebreck A, Zhang JD, Gunawan B, Langer C, Ramadori G, Wiemann S, Sahin O. J Pathol; 2010 Jan 13; 220(1):71-86. PubMed ID: 19768731 [Abstract] [Full Text] [Related] Page: [Next] [New Search]